Found 9 matching trials
A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT) PHASE3 This study will investigate the safety and efficacy of MK-0518 versus efavi...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021) PHASE3 The purpose of this study is to compare the antiretroviral activity of dora...
Show More Location
Multiple Locations
Learn More & Join Trial
Kuwa Free! - Live Free! NA The study investigators are conducting foundational pharmacokinetic (PK) an...
Show More Location
Academic Model Providing Access to Healthcare (AMPATH) Moi Teaching And Referral Hospital (MTRH)
Learn More & Join Trial
Efficacy of Efavirenz 400mg vs. 600mg Combined With Lamivudine and Tenofovir in Treatment Naive HIV Infection NA The present study will be a randomized controlled study in which 500 treatm...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r) PHASE3 The primary purpose of this study is to assess the rate of early discontinu...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) PHASE2 This is a study that will investigate the safety and efficacy of an investi...
Show More Location
Multiple Locations
Learn More & Join Trial
Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression NA According to the Thai National Guidelines for Treatment of HIV/AIDS 2014, t...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study PHASE2 Aim: To evaluate dolutegravir (DTG) pharmacokinetics in pregnant HIV-infect...
Show More Location
Desmond Tutu HIV Foundation
Learn More & Join Trial
Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection PHASE4 2\. Objectives
1. To determine the vitamin D status of African-American HI...
Show More Location
Multiple Locations
Learn More & Join Trial